NEU 6.41% $15.27 neuren pharmaceuticals limited

A possibility worth worth contemplating, page-26

  1. 13,950 Posts.
    lightbulb Created with Sketch. 131
    Not just ACL. Progesterone recently flunked its Phase 3 TBI trials despite showing modest positive effects on mortality rates and function outcomes in earlier Phase 2 trials. results.

    http://www.medpagetoday.com/Neurology/HeadTrauma/49157
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.